320 results on '"Corsico, Angelo Guido"'
Search Results
2. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)
3. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study
4. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
5. Early life exposures contributing to accelerated lung function decline in adulthood – a follow-up study of 11,000 adults from the general population
6. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus
7. Practical dietary advices for subjects with alpha-1 antitrypsin deficiency
8. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
9. A mini-whole lung lavage to treat autoimmune pulmonary alveolar proteinosis (PAP)
10. Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE)
11. An Underestimated Cause of Hemoptysis in a 41-Year-Old Man.
12. Phenotypes and Serum Biomarkers in Sarcoidosis
13. Bayesian networks in the management of hospital admissions: a comparison between explainable AI and black box AI during the pandemics.
14. Severe asthma: One disease and multiple definitions
15. Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH)
16. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
17. Suggestions for lung function testing in the context of COVID-19
18. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
19. Early life exposures contributing to accelerated lung function decline in adulthood : a follow-up study of 11,000 adults from the general population
20. Potential New Inflammatory Markers in Bronchiectasis: A Literature Review.
21. Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.
22. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol
23. Adjuvant Surgical Treatment of Non-Tuberculous Mycobacterial Lung Disease in Chronic Thromboembolic Pulmonary Hypertension: A First Case Report
24. Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study
25. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients
26. Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms
27. Gastritis and gastroesophageal reflux disease are strongly associated with non-allergic nasal disorders
28. The potential role of ICU capacity strain in COVID-19 mortality: comparison between first and second waves in Pavia, Italy
29. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation
30. Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study
31. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study.
32. Spirometric patterns in young and middle-aged adults: a 20-year European study
33. Clinical profile in patients with severe alpha-1 antitrypsin deficiency due to rare genotypes
34. Assessing the ability of MRI in lung cancer mediastinal staging: rationale and preliminary results
35. Testing the novel Q0genova deletion in patient with Alpha1-antitrypsin Deficiency
36. Smoking and hypersensitivity pneumonitis: a single Institution retrospective analysis
37. Non tuberculous mycobacterial pulmonary disease: a single center experience analysis
38. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
39. Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
40. Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study
41. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy
42. Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study.
43. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
44. Spirometric patterns in young and middle-aged adults: a 20-year European study
45. Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency
46. Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey
47. Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
48. Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
49. Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study
50. Electrophysiological evidence of subclinical trigeminal dysfunction in patients with COVID-19 and smell impairment: A pilot study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.